Kentaro Yoshimatsu

Lenvatinib, an angiogenesis inhibitor targeting VEGFR/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage

Yuji Yamamoto, Junji Matsui, Tomohiro Matsushima et al. · Vascular Cell · 2014 · 500 citations · Full text

Medicine, Oncology, Pharmacology +16

Discovery of Novel Antitumor Sulfonamides Targeting G1 Phase of the Cell Cycle

Takashi Owa, Hiroshi Yoshino, Tatsuo Okauchi et al. · Journal of Medicinal Chemistry · 1999 · 325 citations

Medicine, Oncology, Pharmacology +13

Novel sulfonamides as potential, systemically active antitumor agents

Hiroshi Yoshino, Norihiro Ueda, Jun Niijima et al. · Journal of Medicinal Chemistry · 1992 · 233 citations

Medicine, Medicinal Chemistry, Pharmacology +5

Stem Cell Factor/c-kit Signaling Promotes the Survival, Migration, and Capillary Tube Formation of Human Umbilical Vein Endothelial Cells

Junji Matsui, Toshiaki WAKABAYASHI, Makoto Asada et al. · Journal of Biological Chemistry · 2004 · 218 citations · Full text

Life Sciences, Cell Biology, Pharmacology +16

<i>In Vitro</i> Activity of E1210, a Novel Antifungal, against Clinically Important Yeasts and Molds

Mamiko Miyazaki, Takaaki Horii, Katsura Hata et al. · Antimicrobial Agents and Chemotherapy · 2011 · 198 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14